The brokerage believes that Indegene has entered FY27 with a stronger and more diversified growth pipeline, supported by continued expansion within existing accounts, increasing contribution from clients outside the top 20 and traction in GenAI-led solutions across both commercial and medical affairs.
The brokerage believes that Indegene has entered FY27 with a stronger and more diversified growth pipeline, supported by continued expansion within existing accounts, increasing contribution from clients outside the top 20 and traction in GenAI-led solutions across both commercial and medical affairs.
<iframe src="https://hindustansphere.com/embed/cluster/c81aae5f5f15ce3a40af3852bedc5993447dfed1" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Indegene Shares Rise As Axis Securities Initiates Coverage — Check Target Price, Upside Potential"></iframe>
